Abstract
We conducted a case-control association study of the monocyte chemoattractant protein-1 (MCP1) gene -2518 polymorphism in 90 patients with major depressive disorder. Genotyping was performed by polymerase chain reaction methods. We found significant differences in genotype and allele frequencies. The present study suggests that this polymorphism may confer a susceptibility to major depressive disorder in the Korean population.
| Original language | English |
|---|---|
| Pages (from-to) | 279-281 |
| Number of pages | 3 |
| Journal | Psychiatry Research |
| Volume | 127 |
| Issue number | 3 |
| DOIs | |
| State | Published - 15 Jul 2004 |
Bibliographical note
Funding Information:This study was supported by a grant of the Korea Health 21 R&D project (02-PJ1-PG3-20506-0001), Ministry of Health & Welfare, Republic of Korea.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- MCP1 gene -2518 polymorphism
- Major depressive disorder
Fingerprint
Dive into the research topics of 'Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver